Novohradský V., Bergamo A., Cocchietto M., Zajac J., Brabec V., Mestroni .., Sava G. Influence of the binding of reduced NAMI-A to human serum albumin on the pharmacokinetics and biological activity. Dalton Transactions (print). 2015.

Prachařová J., Saltarella .., Radošová Muchová T., Scintilla S., Novohradský V., Nováková O., Intini FP., Pacifico C., Natile G., Ilík P., Brabec V., Kašpárková J. Novel antitumor cisplatin and transplatin derivatives containing 1-methyl-7-azaindole: Synthesis, characterization, and cellular responses. Journal of Medicinal Chemistry. 2015.

Novohradský V., Zerzánková L., Štěpánková J., Kisová A., Kostrhunová H., Zhe L., Sadler PJ., Kašpárková J., Brabec V. A dual-targeting, apoptosis-inducing organometallic half-sandwich iridium anticancer complex. Metallomics. 2014.

Novohradský V., Zerzánková L., Štěpánková J., Vrána O., Raveendran R., Gibson D., Kašpárková J., Brabec V. Antitumor platinum(IV) derivatives of oxaliplatin with axial valproato ligands. Journal of Inorganic Biochemistry. 2014.

Novohradský V., Zhe L., Vojtíšková M., Sadler PJ., Brabec V., Kašpárková J. Mechanism of cellular accumulation of an iridium(III) pentamethylcyclopentadienyl anticancer complex containing a C,N-chelating ligand. Metallomics. 2014.

Frýbortová M., Nováková O., Štěpánková J., Novohradský V., Gibson D., Kašpárková J., Brabec V. Activation of trans geometry in bifunctional mononuclear platinum complexes by a non-bulky methylamine ligand. Journal of Inorganic Biochemistry. 2013.

Mlčoušková J., Malina J., Novohradský V., Kašpárková J., Komeda S., Brabec V. Energetics, conformation, and recognition of DNA duplexes containing a major adduct of antitumor azolato-bridged dinuclear Pt II complex. Biochimica et Biophysica Acta - General Subjects. 2012.

Olivová R., Štěpánková J., Muchová T., Novohradský V., Nováková O., Vrána O., Kašpárková J., Brabec V. Mechanistic insights into toxic effects of a benzotriazolate-bridged dinuclear platinum(II) compound in tumor cells. Inorganica Chimica Acta. 2012.